Embody vs RxActivate: Pricing, process, and what is disclosed
Comparing Embody vs RxActivate shows a clear contrast: Embody公开s low, fixed prices up front, while RxActivate requires a gated intake before revealing any plan or price. Early verdict: choose Embody for immediate price transparency and fast shipping; choose RxActivate if you want clinician-matched plans and prefer eligibility screening before cost disclosure.
See Embody pricing and sign up
Price transparency and starting cost
Embody lists specific starting prices: compounded semaglutide at $69/month, noted as cut from $299, and compounded tirzepatide at $119/month. Embody describes flat locked in monthly pricing, no monthly membership, cancel anytime, and that final pricing may vary based on dose and clinician recommendation. By contrast, RxActivate shows no price or billing terms before the contact information gate. Its starting price is unverified because pricing is gated behind completion of the medical eligibility questionnaire and submission of name, email and phone number.
Start RxActivate eligibility questionnaire
Eligibility flow and clinician review
Both providers use clinician review, but they present it differently. Embody offers prescription and telemed visits included and states licensed provider review handled entirely online. RxActivate emphasizes a two-minute eligibility questionnaire and clinician-matched GLP-1 plans, with treatment available only when a licensed clinician determines it is medically appropriate. RxActivate requests goal, height, weight, target weight, timeline, medication history, sex assigned at birth, date of birth, state and safety screening before revealing plans.
Medication format and regulatory notes
Embody offers compounded semaglutide and compounded tirzepatide; the source explicitly notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. RxActivate notes that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable; it also states that when compounded medications are offered, they are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Shipping, membership, and cancellation
Embody advertises free shipping with delivery in 1–2 days after clinician approval, no long-term commitment, and cancel anytime. RxActivate does not disclose shipping, membership, cancellation, billing commitment, or medication fees before the contact-information gate; the flow displayed likely eligibility but required contact info before revealing any plan or price.
Five key differences at a glance
| Criteria | Embody | RxActivate |
|---|---|---|
| Starting price | $69/month semaglutide; $119/month tirzepatide | Unverified; pricing gated behind intake |
| Price visibility before signup | Shown up front | Hidden until contact info provided |
| Medication type | Compounded semaglutide and tirzepatide | Clinician-matched; compounded when offered may be used |
| Shipping promise | Free, arrives in 1–2 days after approval | Not disclosed before intake |
| Eligibility flow | Licensed provider review online | Two-minute eligibility questionnaire with state and safety screening |
Who each provider seems best for
Embody is described as best for cost-driven patients who want a straightforward GLP-1 program without paying for premium add-ons. The source emphasizes lowest entry price, fast free shipping, and no monthly membership. RxActivate is described as best for people who confirm eligibility, medication, total cost, renewal terms and state availability before enrollment; its flow is clinician-matched and requires intake information before prices are shown.
Check Embody availability and details
Complete RxActivate intake to view plans
Regulatory and safety reminders
Both sources include regulatory notes: Embody states that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. RxActivate notes that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable, and that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Conclusion: Embody vs RxActivate
In the Embody vs RxActivate comparison, the decisive difference is transparency versus gated clinician matching. Embody provides clear starting prices and fast free shipping after approval, while RxActivate prioritizes clinician-matched plans and requires an eligibility flow and contact information before disclosing pricing or plan details.
Choose Embody if you want upfront pricing ($69/month semaglutide; $119/month tirzepatide), free 1–2 day shipping after approval, no membership, and a low-cost, no-frills telehealth option. Choose RxActivate if you prefer a clinician-matched intake process and want eligibility and state screening completed before seeing medication and total cost.